#72
Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians need to screen patients for cannabis use before surgery since it can increase intraoperative heart rate, cause airway irritation, and alter anesthetic drug efficacy, potentially compromising patient safety. Patients should understand that cannabis use in the perioperative period may require anesthesiologists to adjust dosing protocols and increase monitoring, making honest disclosure of use critical for optimal surgical outcomes.
Cannabis use perioperatively presents significant anesthetic and physiologic challenges that clinicians must anticipate during preoperative assessment. Acute cannabis consumption increases heart rate and can irritate airways, potentially complicating hemodynamic stability and airway management during general anesthesia. Additionally, cannabis use may alter the pharmacokinetics and pharmacodynamics of anesthetic agents, making anesthetic depth less predictable and increasing the risk of inadequate anesthesia or adverse cardiovascular events. These effects warrant explicit preoperative questioning about recent cannabis use, timing, and route of administration to allow anesthesiologists to adjust their approach accordingly. Clinicians should counsel surgical patients to abstain from cannabis for a sufficient period before elective procedures and communicate any cannabis use to the surgical team. Given the rising prevalence of cannabis use, preoperative evaluation should routinely include cannabis screening to optimize perioperative safety and anesthetic outcomes.
“What I tell patients is straightforward: cannabis use within two weeks of surgery can genuinely complicate anesthesia management and increase cardiovascular stress, and I need accurate information about their consumption patterns to keep them safe, which means I need them to be honest with me about frequency and timing.”
? While the post highlights legitimate perioperative concerns about cannabis, clinicians should recognize that the actual risk profile depends heavily on route of administration, timing of last use, individual tolerance, and frequency of consumption. Smoked cannabis does pose genuine risks including airway irritation, sympathomimetic effects on heart rate and blood pressure, and potential interactions with anesthetic agents—particularly relevant for patients with cardiovascular or respiratory comorbidities. However, the severity of these effects varies considerably; occasional users may show different responses than chronic users, and the timing of last use before surgery significantly influences perioperative hemodynamic stability. In practice, the most critical step is asking patients directly about cannabis use during preoperative assessment, documenting frequency and route, and discussing the benefits of abstinence in the days preceding elective procedures, while recognizing that abrupt discontinuation itself may cause anxiety or withdrawal symptoms that complicate anesthesia planning.
💬 Join the Conversation
Have a question about how this applies to your situation?
Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers?
Join the forum discussion →
FAQ
This News item was assembled from structured source metadata and pipeline scoring.
Have thoughts on this? Share it:
